Stocktoria

Almirall, S.A. ALM.MC

ES · Bolsa de Madrid · XMAD · stock · Healthcare · website

Almirall, S.A. financials (annual)

Revenue
€863.2M €894.5M €985.7M €1.11B 2022202320242025
Net income
€4.3M -€38.5M €10.1M €46.2M 2022202320242025
Free cash flow
€38.6M -€65.8M -€664000 €37.2M 2022202320242025

Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022
Revenue€1.1B€985.7M€894.5M€863.2M
Gross profit€871.6M€767.7M€682.0M€662.5M
R&D expense€96.0M€79.0M€66.9M€64.3M
SG&A expense€130.1M€131.6M€119.1M€42.4M
Operating income€66.8M€46.8M€41.2M€68.8M
Interest expense€8.4M€8.2M€7.2M€7.4M
Income tax€28.3M€16.4M€21.3M€26.7M
Net income€46.2M€10.1M-€38.5M€4.3M
EPS (diluted)€0.22€0.05€-0.17€0.02
Operating cash flow€174.5M€160.8M€93.5M€155.1M
Free cash flow€37.2M-€664,000-€65.8M€38.6M
Cash & equivalents€337.8M€377.1M€388.0M€248.8M
Inventory€178.1M€171.7M€167.4M€129.9M
Goodwill€316.0M€316.0M€316.0M€316.0M
Total assets€2.3B€2.4B€2.4B€2.1B
Total debt€342.9M€408.8M€403.2M€403.9M
Total liabilities€850.0M€908.3M€911.6M€829.0M
Shareholders' equity€1.5B€1.5B€1.5B€1.3B

Growth · year-over-year · Revenue CAGR 8.7%

MetricFY2025FY2024FY2023FY2022
Revenue growth+12.4%+10.2%+3.6%
Net income growth+354.9%-998.7%
EPS growth+340.0%-1000.0%
Free cash flow growth-270.4%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · ES · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.